信實集團(RELI.US)斥資2.2億美元與新美亞電子(SANM.US)建立合資企業以推動印度電子製造業發展
格隆匯3月3日丨印度信實集團(RELI.US)週四表示,將斥資2.2億美元與新美亞電子(SANM.US)建立合資企業,以推動印度電子製造業發展。信實集團在一份監管文件中表示,該合資公司旨在為5G通信、雲基礎設施、醫療保健系統、清潔技術以及國防和航空航天製造硬件,同時服務於國內和國際市場。億萬富翁穆克什·安巴尼的信實集團在通過信實集團的一個部門對新美亞電子現有的印度公司進行投資後,將持有該合資公司50.1%的股份。Sanmina則將把其現有的製造業合同交給該合資公司。所有的生產活動最初將在新美亞電子位於印度南部城市金奈的園區進行,並可選擇在印度國內其他生產基地進行擴展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.